LINK Medical has announced that Dr Austin Smith, a leading oncology clinician with specialist expertise in early development and strategy, joined the company as Vice President Clinical Development on December
We recently received a question from a reader who found an out-of-specification temperature sensor that had been monitoring a controlled environment for one year before being taken out of service for calibration. This is a common scenario.
The Board of Directors of Immunicum has announced that, by mutual agreement, Carlos de Sousa has resigned as CEO of Immunicum effective immediately. The Board has appointed Alex Karlsson-Parra, Immunicum’s
The Swedish government has presented its national life science strategy – a point of departure for them to turn propositions and ambitions into reality, states SwedenBIO. The strategy is very
Baxter will include Medow’s IV-bracelet in its product catalogue for distribution in Sweden. Swedish startup Medow has developed an IV-bracelet, a bracelet which effectively secures intravenous tubes for example at
Monday December 9th, Moberg Pharma announced results from the first study in the Phase 3 program for MOB-015, where the primary endpoint and the two key secondary endpoints were met.
Swedish women’s health company Gedea Biotech has been awarded €3 million by EU’s Horizon 2020 to accelerate introduction of antibiotic-free treatment for vaginal infections. Gedea Biotech has announced that it
Recipharm has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW system that will support inhalation and nasal product development. The newly
Medivir has announced that the company has been awarded the International Diamond Prize for Excellence in Quality 2019. The Prize, run by the European Society for Quality Research (ESQR), recognizes
Oncopeptides has presented updated data from its ongoing Phase 2 ANCHOR (OP-104) triple combination study. In the data presented at the ASH Annual Meeting 2019, melflufen and dexamethasone demonstrated positive
We recently received a question from a reader who found an out-of-specification temperature sensor that had been monitoring a controlled environment for one year before being taken out of service for calibration. This is a common scenario.
During its first year the bioprocess pilot-scale facility in Uppsala has hosted fifteen national and international projects and more than 2 000 study visits. The not-for-profit innovation center and testbed
Cantargia has announced that its research platform CANxx has progressed with the start of a drug development project, CAN10. The project originates from inhibition of three inflammatory cytokine systems (IL-1,
BioArctic has announced that data from the ongoing BAN2401 Phase 2b open-label extension study in early Alzheimer’s disease patients was presented by Eisai at the Clinical Trials in Alzheimer’s Disease
Monday December 9th, Moberg Pharma announced results from the first study in the Phase 3 program for MOB-015, where the primary endpoint and the two key secondary endpoints were met.
Trastuzumab deruxtecan achieved a tumour response rate of 60.9% in the Phase II HER2-positive metastatic breast cancer trial. AstraZeneca and Daiichi Sankyo have presented positive detailed data from the global
Pharmaceuticals in the environment is a growing problem of global concern. Drugs taken by humans and animals find their way into rivers, lakes and even drinking water and can have
IVL Swedish Environmental Research Institute and Simrishamn Municipality have tested a completley new treatment system that has now been added to the Stengården sewage plant in Simrishamn, Sweden. “Removing pharmaceutical
Nordic efforts to prevent pharmaceuticals affecting the environment include Danish management of hospital wastewater and a Swedish large-scale sewage plant for removal of pharmaceutical residues. Wastewater from hospitals can contain
Professor Honjo did not set out to find a cure for cancer but he is glad he did not give up and believes cancer immunotherapy will be the Number One
When your passion and lifelong work are the same. Great things can happen. Just ask James Allison.
The 2018 Nobel Prize in Medicine was awarded to James P. Allison and Tasuku Honjo for ther pioneering work in cancer immunotheraphy.
The Temperature Control and Logistics forum remains the industries foremost operational and hands on conference to discuss everything logistics, supply chain and temperature controlled for the Pharmaceutical Industry. Our vision for 2020
The Athera Board of Directors has announced that James Hall is the new Chief Executive Officer in the company. Carina Schmidt steps down after nearly 13 years as CEO but
Jonas Lindqvist brings with him decades of leadership experience in a regulated environment which was a critical factor in the selection process, states the company. As AMRA focuses on operational
Amy Arthur has been appointed new General Manager of Boehringer Ingelheim Sweden. During the past 16 years Arthur, originally from the UK, has been working within different areas of business
How do you take an invention further and make the right decisions to protect your innovation? Patent engineer Maria Lundström provides a helping hand in the delicate processes of patents,
ISSUE 04 2019 // This issue features an exclusive interview with business woman Barbro Ehnbom, within life sciences perhaps best known as the founder of SALSS. This issue also contains a mini-theme on Drug development. We also reveal new Nordic findings from CryoEM data and we have spoken to Ed Boyden, the winner of the Lennart Nilsson Award.
Cantargia has announced that its research platform CANxx has progressed with the start of a drug development project, CAN10. The project originates from inhibition of three inflammatory cytokine systems (IL-1,
BioArctic has announced that data from the ongoing BAN2401 Phase 2b open-label extension study in early Alzheimer’s disease patients was presented by Eisai at the Clinical Trials in Alzheimer’s Disease
Monday December 9th, Moberg Pharma announced results from the first study in the Phase 3 program for MOB-015, where the primary endpoint and the two key secondary endpoints were met.
Trastuzumab deruxtecan achieved a tumour response rate of 60.9% in the Phase II HER2-positive metastatic breast cancer trial. AstraZeneca and Daiichi Sankyo have presented positive detailed data from the global
LINK Medical has announced that it will carry out a pivotal phase III clinical trial on behalf of Sedana Medical, a Swedish medical technology and pharmaceutical company. The international study
Oncopeptides has presented updated data from its ongoing Phase 2 ANCHOR (OP-104) triple combination study. In the data presented at the ASH Annual Meeting 2019, melflufen and dexamethasone demonstrated positive
GeNeuro has announced a collaboration for a new clinical trial of temelimab in multiple sclerosis (MS) with clinical researchers of Karolinska Institutet and the Academic Specialist Center (ASC), Stockholm, Sweden.
Scandinavian Biopharma reports successful results of the ETEC vaccine candidate ETVAX in a placebo-controlled phase I/II study in infants and children in Bangladesh. The successful results of the Phase I/II
Follicum has announced that the company has signed a collaboration agreement with proDERM for conducting the new clinical trial with a cream-like formulation of FOL-005 to be tested on alopecia
A new scientific study showing how fish behavior is being changed by pharmaceuticals entering water habitats after being incorrectly disposed highlights the urgent need for research into the impact of
Spinchem shares about 40 million SEK in an international research project funded by the European Union. ”This is good timing for SpinChem since our strategy is to create new environmentally
A novel map of all proteins secreted to human blood is described in a paper by Mathias Uhlen et al. entitled “The Human Secretome”, published in the journal Science Signaling.
OrganoClick receives SEK 3.7 million in funding from strategic innovation program Bioinnovation for development of biobased binders for nonwoven. OrganoClick has been granted funding of SEK 3.7 million for development
Sarah McGarrity’s research focuses on endothelial cells, which are important for blood pressure and clotting, and her findings might give us a better understanding and lead to treatments for conditions
Researchers at Karolinska Institutet have shown that the memory capacity and learning capability of mice improve if lithium treatment is given after the irradiation of the brain. Mice that were
